Digital Therapeutics, Inc. — Form D
Digital Therapeutics, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-11. The offering totals $50.5M, of which $50.5M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-04-11
- Form: D
- Accession: 0001805173-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $50.5M
- Amount sold: $50.5M
- Investors: 10
- Date of first sale: 2023-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-510304
Issuer
- Name: Digital Therapeutics, Inc.
- CIK: 0001805173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1632 1st Ave, New York, NY, 10028
- Phone: (877) 349-7755
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Maroof Ahmed | Director | New York, NY |
| Ben Blume | Director | Mountain View, CA |
| Will Gibbs | Director | New York, NY |
| Maria Maras | Director | New York, NY |
| Gabriel Mecklenburg | Director | New York, NY |
| Yusuf Sherwani | Director | New York, NY |
| Sarim Siddiqui | Director | New York, NY |
| Maroof Ahmed | Executive Officer | New York, NY |
| Yusuf Sherwani | Executive Officer | New York, NY |
| Sarim Siddiqui | Executive Officer | New York, NY |
| Christian Scherrer | Director | NEW YORK, NY |
Other filings by this issuer (3)
More